Relative Strength Chart BeOne Medicines AG
Equities
ONC
US07725L1026
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.90 USD | -2.56% |
|
-5.20% | +74.81% |
| Nov. 26 | Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Key Economic Data Deluge | MT |
| Nov. 26 | BeOne Medicine Wins FDA Priority Review for Mantle Cell Lymphoma Drug | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BEONE MEDICINES AG | Other Biotechnology & Medical Research | -2.56% | -5.20% | +74.81% | +57.04% | +44.88% | 35.73B |  |  | |
- Stock Market
- Equities
- ONC Stock
- Charts BeOne Medicines AG
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
